4. Lau P, Bossers K, Janky RS, Salta E, Frigerio CS, Barbash S, Rothman R, Sierksma AS, Thathiah A, Greenberg D, Papadopoulou AS.
Alteration of the micro RNA network during the progression of Alzheimer''s disease. Mol Med 2013; 5(10): 1613-1634.
9. Rudnicki M, Perco P, D′ haene B, Leierer J, Heinzel A, Mühlberger I, Schweibert N, Sunzenauer J, Regele H, Kronbichler A, Mestdagh P.
Renal micro RNA‐and RNA‐profiles in progressive chronic kidney disease. Eur J Clin Invest 2016; 46(3): 213-226.
22. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC.
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010; 122(11_suppl_1): S124-S131.
27. Yamamoto Y, Kondo S, Matsuzaki J, Esaki M, Okusaka T, Shimada K, Murakami Y, Enomoto M, Tamori A, Kato K, Aoki Y.
Highly sensitive circulating microRNA panel for accurate detection of hepatocellular carcinoma in patients with liver disease. Hepatol Commun 2020; 4(2): 284-297.
35. Magayr TA, Song X, Streets AJ, Vergoz L, Chang L, Valluru MK, Yap HL, Lannoy M, Haghighi A, Simms RJ, Tam FW.
Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for autosomal dominant polycystic kidney disease. Kidney Int 2020; 98(2): 420-435.
41. Masud MK, Mahmudunnabi RG, Aziz NB, Stevens CH, Do‐Ha D, Yang S, Blair IP, Hossain MS, Shim YB, Ooi L, Yamauchi Y.
Sensitive Detection of Motor Neuron Disease Derived Exosomal miRNA Using Electrocatalytic Activity of Gold‐Loaded Superparamagnetic Ferric Oxide Nanocubes. Chem Electro Chem 2020; 7(16): 3459-3467.